The Asia Pacific Pancrelipase Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030).
Cystic fibrosis, a genetic disease affecting the respiratory, digestive, and reproductive systems, leads to pancreatic insufficiency. This drug is a cornerstone in CF management, mitigating malabsorption issues and ensuring proper nutrition. Individuals with chronic pancreatitis often experience a decline in pancreatic function. This drug becomes instrumental in managing symptoms, preventing malnutrition, and improving the quality of life for patients grappling with this debilitating condition.
Real-world evidence obtained through health economics and outcome research (HEOR) studies provides insights into the drug’s long-term effectiveness and safety in diverse patient populations. This evidence is crucial for translating clinical trial outcomes into real-world clinical practice. Health economic modeling helps predict the long-term implications of using this drug to manage pancreatic disorders. These models provide decision-makers with insights into the economic sustainability of therapy. HEOR studies conduct budget impact analyses to estimate the financial consequences of incorporating this medicine into healthcare budgets.
According to Invest India, the telemedicine industry is India's maximum potential eHealth segment, which is expected to reach $5.4 Bn by 2025. Telemedicine platforms can provide prescription services for this medicine and allow for easy refills. Patients with chronic pancreatic conditions can receive ongoing care and prescription renewals through virtual consultations, promoting treatment continuity. Telemedicine facilitates access to specialized healthcare professionals, including gastroenterologists who specialize in diagnosing and treating pancreatic disorders. Patients in remote or underserved areas can consult with experts without extensive travel. Therefore, the factors mentioned above will propel the market growth in this region.
The China market dominated the Asia Pacific Pancrelipase Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $143.5 Million by 2030. The Japan market is registering a CAGR of 5.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.8% during (2023 - 2030).
Free Valuable Insights: The Global Pancrelipase Market is Predict to reach $2.6 Billion by 2030, at a CAGR of 4.7%
Based on Age, the market is segmented into Adults & Geriatrics, and Children. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on Application, the market is segmented into Chronic Pancreatitis, Cystic Fibrosis, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Organon & Co.
- Digestive Care, Inc.
- AbbVie, Inc.
- Vivus LLC
- Laboratorio Opoterápico Argentino S.A.
- Nestle S.A
- Scientific Protein Laboratories, LLC (Hepalink)
Asia Pacific Pancrelipase Market Report Segmentation
By Age
- Adults & Geriatrics
- Children
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Application
- Chronic Pancreatitis
- Cystic Fibrosis
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
TABLE 1 Asia Pacific Pancrelipase Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Pancrelipase Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Adults & Geriatrics Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Adults & Geriatrics Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Children Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Children Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Online Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Chronic Pancreatitis Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Chronic Pancreatitis Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Cystic Fibrosis Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Cystic Fibrosis Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Pancrelipase Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Pancrelipase Market by Country, 2023 - 2030, USD Million
TABLE 27 China Pancrelipase Market, 2019 - 2022, USD Million
TABLE 28 China Pancrelipase Market, 2023 - 2030, USD Million
TABLE 29 China Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 30 China Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 31 China Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 32 China Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 33 China Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 34 China Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 35 Japan Pancrelipase Market, 2019 - 2022, USD Million
TABLE 36 Japan Pancrelipase Market, 2023 - 2030, USD Million
TABLE 37 Japan Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 38 Japan Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 39 Japan Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Japan Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Japan Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 42 Japan Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 43 India Pancrelipase Market, 2019 - 2022, USD Million
TABLE 44 India Pancrelipase Market, 2023 - 2030, USD Million
TABLE 45 India Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 46 India Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 47 India Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 48 India Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 49 India Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 50 India Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 51 South Korea Pancrelipase Market, 2019 - 2022, USD Million
TABLE 52 South Korea Pancrelipase Market, 2023 - 2030, USD Million
TABLE 53 South Korea Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 54 South Korea Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 55 South Korea Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 South Korea Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 South Korea Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 58 South Korea Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 59 Singapore Pancrelipase Market, 2019 - 2022, USD Million
TABLE 60 Singapore Pancrelipase Market, 2023 - 2030, USD Million
TABLE 61 Singapore Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 62 Singapore Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 63 Singapore Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 Singapore Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 Singapore Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 66 Singapore Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 67 Malaysia Pancrelipase Market, 2019 - 2022, USD Million
TABLE 68 Malaysia Pancrelipase Market, 2023 - 2030, USD Million
TABLE 69 Malaysia Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 70 Malaysia Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 71 Malaysia Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 72 Malaysia Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 73 Malaysia Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 74 Malaysia Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 75 Rest of Asia Pacific Pancrelipase Market, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Pancrelipase Market, 2023 - 2030, USD Million
TABLE 77 Rest of Asia Pacific Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 79 Rest of Asia Pacific Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 81 Rest of Asia Pacific Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 83 Key Information – Organon & co.
TABLE 84 Key Information – Digestive Care, Inc.
TABLE 85 Key Information – Laboratorio Opoterápico Argentino S.A.
TABLE 86 Key Information – Scientific Protein Laboratories, LLC
TABLE 87 Key information – AbbVie, Inc.
TABLE 88 Key Information – Vivus LLC
TABLE 89 Key Information – Nestle S.A
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Pancrelipase Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Pancrelipase Market
FIG 4 Porter’s Five Forces Analysis – Pancrelipase Market
FIG 5 Asia Pacific Pancrelipase Market share by Age, 2022
FIG 6 Asia Pacific Pancrelipase Market share by Age, 2030
FIG 7 Asia Pacific Pancrelipase Market by Age, 2019 - 2030, USD Million
FIG 8 Asia Pacific Pancrelipase Market share by Distribution Channel, 2022
FIG 9 Asia Pacific Pancrelipase Market share by Distribution Channel, 2030
FIG 10 Asia Pacific Pancrelipase Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 Asia Pacific Pancrelipase Market share by Application, 2022
FIG 12 Asia Pacific Pancrelipase Market share by Application, 2030
FIG 13 Asia Pacific Pancrelipase Market by Application, 2019 - 2030, USD Million
FIG 14 Asia Pacific Pancrelipase Market share by Country, 2022
FIG 15 Asia Pacific Pancrelipase Market share by Country, 2030
FIG 16 Asia Pacific Pancrelipase Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Nestle S.A